Valuation: Abbott Laboratories

Market Cap 184B 998B 165B 151B 137B 256B 17,449B 261B 1,805B 725B 9,179B 690B 675B 28,946B P/E 2026 *
35.1x
P/E 2027 * 25.6x
Enterprise Value 207B 1,126B 186B 171B 155B 289B 19,685B 295B 2,037B 818B 10,355B 778B 762B 32,656B EV / Sales 2026 *
4.15x
EV / Sales 2027 * 3.81x
Free-Float
86.16%
Yield 2026 *
2.44%
Yield 2027 * 2.6%
1 day-3.01%
1 week+11.64%
Current month+12.56%
1 month+12.56%
3 months+8.10%
6 months+28.30%
Current year-16.23%
1 week 45.14
Extreme 45.14
49.19
1 month 40.4
Extreme 40.4
49.19
Current year 33.5
Extreme 33.5
57.5
1 year 33.5
Extreme 33.5
58.85
3 years 33.5
Extreme 33.5
67.65
5 years 33.5
Extreme 33.5
67.65
10 years 10.59
Extreme 10.593333
67.65
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Change 5-day change 1-year change 3-year change Capi.($)
-3.01%+11.64% - - 184B
+1.56%+2.41%-14.82%+14.19% 184B
-6.38%-4.98%-20.90%+11.15% 112B
-0.59%+1.18%+6.12%+37.97% 118B
+3.42%+1.71%-42.32%+9.52% 94.58B
+0.09%-0.05%-3.04%+78.44% 63.13B
-0.46%+0.42%+8.19%+82.97% 55.66B
-0.23%-0.52%+10.31%-21.19% 53.9B
-4.30%-1.64%-12.30%+39.06% 43.42B
+0.58%+2.00%-1.07%-6.43% 34.68B
Average -0.93%+0.06%-7.76%+27.30% 84.36B
Weighted average by Cap. -0.98%+0.23%-10.66%+25.22%

Financials

2026 *2027 *
Net sales 49.96B 271B 44.75B 41.16B 37.29B 69.71B 4,744B 71.02B 491B 197B 2,496B 188B 184B 7,870B 53.53B 291B 47.94B 44.1B 39.96B 74.69B 5,083B 76.08B 526B 211B 2,674B 201B 197B 8,431B
Net income 5.64B 30.64B 5.05B 4.65B 4.21B 7.87B 536B 8.02B 55.44B 22.26B 282B 21.18B 20.73B 889B 7.66B 41.61B 6.86B 6.31B 5.72B 10.69B 728B 10.89B 75.28B 30.22B 383B 28.76B 28.15B 1,207B
Net Debt 23.55B 128B 21.1B 19.4B 17.58B 32.87B 2,237B 33.48B 231B 92.89B 1,176B 88.4B 86.52B 3,710B 20.14B 109B 18.04B 16.59B 15.03B 28.1B 1,912B 28.63B 198B 79.42B 1,006B 75.58B 73.97B 3,172B
Projected Income Statement - Annual - Abbott Laboratories
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-10-30 R$48.05 +3.00% 79
26-10-29 R$46.65 -5.16% 109
26-10-28 R$49.19 +6.70% 555
26-10-27 R$46.10 -1.91% 87
26-10-26 R$47.00 +9.20% 2,501
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Abbott Laboratories
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
106.20USD
Average target price
118.52USD
Spread / Average Target
+11.60%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Abbott Laboratories